Efficacy of Topical Cyclosporine Versus Tears for Improving Visual Outcomes Following Multifocal IOL Implantation

Completed · Phase 4

Conditions studied: Cataract, Dry Eye

In brief

The purpose of this study is to evaluate the efficacy on quality of vision and dry eye signs and symptoms in patients undergoing cataract surgery using the ReZoom® multifocal IOL.

Key facts

Study ID

NCT00349583

Run by

Innovative Medical

Last updated by the study team

2007-06-01

Who can join

Age: 50 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• · Males or females > 50 years old
• Scheduled to undergo bilateral phacoemulsification with implantation of a multifocal IOL.
• Likely to complete all study visits and able to provide informed consent
• Visual potential of 20/25 or better

You may not qualify if…

• · Prior use of topical cyclosporine
• Known contraindications to any study medication or ingredients
• Active ocular diseases or uncontrolled systemic disease
• Active ocular allergies

Where it is running

• Ophthalmic Consultants of Long Island — Rockville Centre, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.